Home/ Supplements/ Omega 3/ RxOmega-3

RxOmega-3

product on market Softgel Capsule Natural Factors Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Pharmaceutical grade fish oil concentrate provides omega-3 fatty acids, which have strong evidence for supporting cardiovascular health. Research indicates these nutrients help maintain healthy triglyceride levels and support overall heart function. The ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for RxOmega-3
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Fat/Fatty Acid
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 {Calories}
Total Fat
0.5 Gram(s) (1% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Enteriprure(TM) Softgel Vitamin E
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: 1 softgel 1–3 times per day before each meal or as directed by a health professional.

Warnings & Precautions

Keep out of the reach of children.

Sealed for your protection. Do not use if seal is broken.

Formulation Notes

RxOmega-3 is a pharmaceutical-grade fish oil providing one of the highest potencies of EPA and DHA available in a Mini-Gel for easy swallowing.

Molecularly distilled and guaranteed for purity and safety from environmental pollutants like PCBs and mercury or other harmful compounds, RxOmega-3 surpasses the strictest international standards for quality.

Contains no artificial colors, preservatives, or sweeteners; no dairy, sugar, wheat, gluten, yeast, soy, corn, egg, shellfish, salt, tree nuts, or GMOs.

Pharmaceutical Grade Fish Oil 500 mg EPA/DHA

Additional Information

Mini-Gels

Manufactured by Natural Factors to ensure safety and potency in accordance with Good Manufacturing Practices (GMP) of the FDA and Health Canada.

For freshness, store in a cool, dry place.

PRODUCT OF CANADA

Recyclable container and label.

Purity&Potency Guaranteed

NO FISHY AFTERTASTE

R1

{Softgel} 45% Smaller

Metadata

Product Details

UPC / SKU0 68958 35495 8
DSLD Entry Date2014-10-27
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID38147
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.